Skip to content
ContentLora

    Tip: press / anywhere to search.

    Explainer

    Malaria explained: parasites, mosquitoes and the new vaccines

    Malaria is caused by a parasite spread by the bites of infected Anopheles mosquitoes, and it does not pass from person to person.[1] WHO estimates 282 million cases and 610,000 deaths in 2024, 95% of them in the WHO African Region.[2][3] WHO recommended the first malaria vaccine, RTS,S, in 2021 and a second, R21, in 2023, and by May 2026 25 African countries were giving them to children.[4][5] Drug and insecticide resistance threaten progress, and 2024 funding reached less than half of the 2025 target.[6][7][8]

    Editor reviewedStrict sourcingUpdated Explainer18 claims · 100% primaryInfectious disease, mRNA and next-gen vaccines, Health and medicine

    This page explains malaria for general readers. It is not medical advice. If you develop a fever during or after a trip to an area with malaria, seek medical care promptly and say where you have travelled. Travellers should talk to a clinician about prevention well before departure.

    Malaria is caused by a parasite. It spreads to people mostly through the bites of infected female Anopheles mosquitoes and does not spread from person to person.[1]

    Parasites, mosquitoes and symptoms

    Five species of Plasmodium parasite cause malaria in humans. P. falciparum is the deadliest and the most common in Africa; P. vivax dominates in most countries outside sub-Saharan Africa.[9]

    The most common early symptoms are fever, headache and chills. Untreated P. falciparum malaria can progress to severe illness and death within 24 hours.[10] Infants, children under 5, pregnant women, travellers and people with HIV or AIDS are at higher risk of severe disease.[11]

    Testing and treatment

    WHO recommends that every suspected case be confirmed with a parasite test, by microscopy or a rapid diagnostic test. It says artemisinin-based combination therapies are the most effective treatment for P. falciparum malaria.[12]

    Those drugs are under pressure. WHO’s World malaria report says antimalarial drug resistance has been confirmed or suspected in at least 8 African countries.[6]

    Prevention: nets, spraying and medicines

    The two core ways of controlling mosquitoes are insecticide-treated nets and indoor residual spraying, but resistance to insecticides among Anopheles mosquitoes threatens progress.[7] An invasive species, Anopheles stephensi, which tolerates many insecticides and thrives in cities, has spread to 9 African countries.[13]

    WHO advises travellers to malaria-endemic areas to consult a doctor several weeks before departure about preventive medicines.[14]

    The vaccines

    Since October 2021 WHO has recommended the RTS,S/AS01 vaccine for children in areas with moderate to high P. falciparum transmission, and in October 2023 it recommended a second vaccine, R21/Matrix-M.[4]

    The evidence comes from different kinds of study. In a clinical trial in areas with highly seasonal malaria, R21 reduced symptomatic cases by 75% in the 12 months after a three-dose series.[15] For RTS,S, an evaluation of the first rollouts, published in The Lancet in May 2026, estimated that 1 in 8 child deaths were averted among eligible children in Ghana, Kenya and Malawi over four years.[16]

    As of May 2026, 25 endemic countries in Africa were offering malaria vaccines in their childhood immunization programmes.[5] For how other vaccine platforms work, see the vaccines hub.

    The global picture

    WHO estimates there were 282 million malaria cases and 610,000 malaria deaths in 2024, about 9 million more cases than in 2023.[2] The WHO African Region had 95% of cases and deaths, and an estimated 438,000 African children died from malaria.[3]

    There is progress too. WHO estimates that newer tools, including dual-ingredient nets and vaccines, prevented about 170 million cases and 1 million deaths in 2024.[17] By December 2025, 47 countries and 1 territory had been certified malaria-free, including Georgia, Suriname and Timor-Leste in 2025.[18] After a decade in which global funding plateaued, US$3.9 billion was invested in the malaria response in 2024, less than half of the US$9.3 billion target for 2025.[8]

    Other mosquito-borne diseases, spread by different mosquitoes, are covered in dengue explainer.

    More in Infectious disease

    Questions readers ask

    How do you get malaria?

    Mostly through the bites of infected female Anopheles mosquitoes. Malaria is caused by a parasite and does not spread from person to person.[1]

    What are the first symptoms of malaria?

    The most common early symptoms are fever, headache and chills. Untreated P. falciparum malaria can progress to severe illness and death within 24 hours, and WHO recommends confirming every suspected case with a parasite test.[10][12]

    Who is most at risk of severe malaria?

    Infants, children under 5, pregnant women, travellers and people with HIV or AIDS. In 2024 an estimated 438,000 African children died of malaria.[11][3]

    Is there a malaria vaccine?

    Yes, two. WHO recommended RTS,S/AS01 for children in 2021 and R21/Matrix-M in 2023. As of May 2026, 25 endemic African countries offered them in childhood immunization programmes.[4][5]

    How well do the malaria vaccines work?

    In a clinical trial in highly seasonal areas, R21 cut symptomatic malaria by 75% in the 12 months after three doses. A 2026 evaluation in Ghana, Kenya and Malawi estimated that RTS,S averted 1 in 8 child deaths among eligible children.[15][16]

    What should travellers do about malaria?

    WHO advises travellers to malaria-endemic areas to consult a doctor several weeks before departure about preventive medicines.[14]

    Sources

    · 18 claims from 1 publisher

    Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.

    1. [1]

      Malaria is caused by a parasite spread mostly through bites of infected female Anopheles mosquitoes; it does not spread from person to person. confirmedas of 2026-11-07

      • Malaria - fact sheet · World Health Organization · Primary source · Overview (retrieved 2026-11-07)
      • Malaria - fact sheet · World Health Organization · Primary source · Overview (retrieved 2026-11-07)
    2. [2]

      WHO estimates 282 million malaria cases and 610,000 malaria deaths in 2024, about 9 million more cases than in 2023. confirmedas of 2026-11-07

    3. [3]

      The WHO African Region had 95% of malaria cases and deaths in 2024, and an estimated 438,000 African children died from malaria that year. confirmedas of 2026-11-07

    4. [4]

      WHO recommended the RTS,S/AS01 malaria vaccine for children in October 2021 and a second vaccine, R21/Matrix-M, in October 2023. confirmedas of 2026-11-07

      • Malaria - fact sheet · World Health Organization · Primary source · Vaccine (retrieved 2026-11-07)
      • Malaria - fact sheet · World Health Organization · Primary source · Vaccine (retrieved 2026-11-07)
    5. [5]

      As of May 2026, 25 endemic African countries were offering malaria vaccines in childhood immunization programmes. confirmedas of 2026-11-07

    6. [6]

      Antimalarial drug resistance has been confirmed or suspected in at least 8 African countries. confirmedas of 2026-11-07

    7. [7]

      Insecticide-treated nets and indoor residual spraying are the two core malaria vector-control tools, but insecticide resistance threatens progress. confirmedas of 2026-11-07

      • Malaria - fact sheet · World Health Organization · Primary source · Vector control (retrieved 2026-11-07)
      • Malaria - fact sheet · World Health Organization · Primary source · Vector control (retrieved 2026-11-07)
    8. [8]

      US$3.9 billion was invested in the malaria response in 2024, less than half of the US$9.3 billion funding target for 2025, after a decade in which global funding plateaued. confirmedas of 2026-11-07

    9. [9]

      Five Plasmodium species cause malaria in humans; P. falciparum is the deadliest and most common in Africa, and P. vivax dominates in most countries outside sub-Saharan Africa. confirmedas of 2026-11-07

      • Malaria - fact sheet · World Health Organization · Primary source · Overview (retrieved 2026-11-07)
      • Malaria - fact sheet · World Health Organization · Primary source · Overview (retrieved 2026-11-07)
    10. [10]

      The most common early malaria symptoms are fever, headache and chills, and untreated P. falciparum malaria can progress to severe illness and death within 24 hours. confirmedas of 2026-11-07

      • Malaria - fact sheet · World Health Organization · Primary source · Symptoms (retrieved 2026-11-07)
      • Malaria - fact sheet · World Health Organization · Primary source · Overview (retrieved 2026-11-07)
    11. [11]

      Infants, children under 5, pregnant women, travellers and people with HIV or AIDS are at higher risk of severe malaria. confirmedas of 2026-11-07

      • Malaria - fact sheet · World Health Organization · Primary source · Symptoms (retrieved 2026-11-07)
    12. [12]

      WHO recommends confirming every suspected malaria case with a parasite test, and says artemisinin-based combination therapies are the most effective treatment for P. falciparum malaria. confirmedas of 2026-11-07

      • Malaria - fact sheet · World Health Organization · Primary source · Treatment (retrieved 2026-11-07)
      • Malaria - fact sheet · World Health Organization · Primary source · Treatment (retrieved 2026-11-07)
    13. [13]

      The invasive mosquito Anopheles stephensi, resistant to many insecticides, has spread to 9 African countries. confirmedas of 2026-11-07

    14. [14]

      WHO advises travellers to malaria-endemic areas to consult a doctor several weeks before departure about preventive medicines. confirmedas of 2026-11-07

      • Malaria - fact sheet · World Health Organization · Primary source · Chemoprophylaxis (retrieved 2026-11-07)
    15. [15]

      In a clinical trial in highly seasonal areas, R21 reduced symptomatic malaria by 75% in the 12 months after a three-dose series. confirmedas of 2026-11-07

    16. [16]

      An evaluation published in The Lancet in May 2026 estimated that 1 in 8 child deaths were averted among children eligible for RTS,S in Ghana, Kenya and Malawi over four years. confirmedas of 2026-11-07

    17. [17]

      WHO estimates that new tools, including dual-ingredient nets and vaccines, prevented about 170 million cases and 1 million deaths in 2024. confirmedas of 2026-11-07

    18. [18]

      By December 2025, 47 countries and 1 territory had been certified malaria-free by WHO, including Georgia, Suriname and Timor-Leste in 2025. confirmedas of 2026-11-07

    Revision history (1)
    1. Page created.

    Created Nov 7, 2026. Last reviewed by an editor on Nov 8, 2026. Next scheduled review: Dec 31, 2026.

    Cite this page

    "Malaria explained: parasites, mosquitoes and the new vaccines." ContentLora, updated Nov 7, 2026. https://contentlora.com/explain/malaria-explained

    Spotted an error? Suggest a correction or emailcorrections@contentlora.com.